Moore Kuehn Encourages GWPH, GNPK, PMBC, and SPFR Investors to Contact Law Firm NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...

First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals NEW YORK, NY--(Marketwired - February 23, 2017) - PharmaCyte Biotech (OTCQB: PMCB) will join GW Pharmaceuticals, Abbott Laboratories and 66 other publicly traded companies in what could be the first...

EQUITY NOTICE: Rosen Law Firm Reminds GW Pharmaceuticals plc Investors of Important March 21, 2016 Deadline in Class Action – GWPH NEW YORK, March 18, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of GW Pharmaceuticals plc securities (NASDAQ:GWPH) from December 4, 2014 through...

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against GW Pharmaceuticals plc – GWPH NEW YORK, March 04, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of GW Pharmaceuticals plc...